14-day Premium Trial Subscription Sign Up For FreeGet Free

Alkermes plc Stock Forecast NASDAQ:ALKS

Price Target and Analyst Ratings

Most Recent Rating

On September 10, 2021 "Mizuho" gave "$33.00 - $36.00" rating for ALKS. The price target was set to $30.17+0.6%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-10 $33.00 - $36.00 Reiterated by Mizuho $30.52 $30.17+0.6%
2021-09-02 $27.00 Downgraded by Bank of America $30.33 $31.250.0%
2021-07-29 $29.00 - $33.00 Target Raised by Mizuho $25.56 $25.55→0.9%
2021-07-29 $23.00 - $25.00 Target Raised by SVB Leerink $25.56 $25.77+6.8%
2021-07-29 $29.00 - $33.00 Reiterated by Mizuho $25.56 $25.77+6.8%
2021-06-02 Neutral Target Raised by HC Wainwright $23.30 $24.00 → $25.00
2021-06-02 Neutral Reiterated by HC Wainwright $23.30 $24.00 → $25.00
2021-06-01 Buy Reiterated by Mizuho $23.15 $29.00
2021-05-05 Neutral Target Raised by HC Wainwright $22.05 $23.00 → $24.00
2021-04-29 Neutral Target Raised by HC Wainwright $21.78 $23.00 → $24.00
2021-04-29 Neutral Reiterated by HC Wainwright $21.78 $23.00 → $24.00
2021-04-26 Buy Target Raised by Mizuho $22.47 $28.00 → $29.00
2021-01-07 Target Raised by Mizuho $20.59 $24.00 → $28.00
2020-12-11 Market Perform Target Raised by SVB Leerink $21.30 $18.00 → $23.00
2020-11-10 Hold Reiterated by HC Wainwright $18.08
2020-10-15 Neutral - Buy Upgraded by Mizuho $17.25 $19.00 → $24.00
2020-10-07 Hold Reiterated by JPMorgan Chase & Co. $16.94
2020-09-30 Neutral Target Lowered by Bank of America $16.57 $21.00 → $19.00
2020-09-21 Hold Reiterated by JPMorgan Chase & Co. $17.20
2020-07-30 Neutral Target Raised by Mizuho $18.40 $16.00 → $19.00
2020-07-30 Neutral - Sell Downgraded by Goldman Sachs Group $18.40 $19.00 → $15.00
2020-07-30 Hold Reiterated by HC Wainwright $18.40 $23.00
2020-04-30 Neutral Reiterated by HC Wainwright $13.71 $25.00 → $23.00
2020-04-29 Hold Reiterated by Mizuho $14.40 $16.00
2020-04-29 Neutral Target Lowered by Piper Sandler $14.40 $22.00 → $21.00
2020-04-29 Average - Hold Target Lowered by Stifel Nicolaus $14.40 $20.00 → $17.00

ALKS Stock Trend

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 33.13% during the next 3 months and, with a 90% probability hold a price between $38.99 and $44.45 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-23 $29.42 $31.47 $33.52
2021-09-24 $29.55 $31.60 $33.65
2021-09-27 $29.68 $31.73 $33.78
2021-09-28 $29.81 $31.86 $33.92
2021-09-29 $29.94 $32.00 $34.05
2021-09-30 $30.07 $32.13 $34.18
2021-10-01 $30.21 $32.26 $34.31
2021-10-04 $30.34 $32.39 $34.44
2021-10-05 $30.47 $32.52 $34.58
2021-10-06 $30.60 $32.65 $34.71
2021-10-07 $30.73 $32.79 $34.84
2021-10-08 $30.87 $32.92 $34.97
2021-10-11 $31.00 $33.05 $35.10
2021-10-12 $31.13 $33.18 $35.23
2021-10-13 $31.26 $33.31 $35.37
2021-10-14 $31.39 $33.45 $35.50
2021-10-15 $31.53 $33.58 $35.63
2021-10-18 $31.66 $33.71 $35.76
2021-10-19 $31.79 $33.84 $35.89
2021-10-20 $31.92 $33.97 $36.03
2021-10-21 $32.05 $34.11 $36.16
2021-10-22 $32.18 $34.24 $36.29
2021-10-25 $32.32 $34.37 $36.42
2021-10-26 $32.45 $34.50 $36.55
2021-10-27 $32.58 $34.63 $36.69
2021-10-28 $32.71 $34.76 $36.82
2021-10-29 $32.84 $34.90 $36.95
2021-11-01 $32.98 $35.03 $37.08
2021-11-02 $33.11 $35.16 $37.21
2021-11-03 $33.24 $35.29 $37.34

About Alkermes plc

Alkermes plc Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. The company’s marketed products include ARISTADA (aripiprazole lauroxil) for the treatment of schizophrenia; VIVITROL (naltrexone for extended-release injectable suspension) for the treatment of alcohol and opioid dependence; INVEGA SUSTENN... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT